AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,722,956 | +6.2% | 361,452 | +69.9% | 0.00% | 0.0% |
| Q2 2023 | $3,506,928 | +631.1% | 212,799 | +306.4% | 0.00% | – |
| Q1 2023 | $479,691 | +136.6% | 52,368 | +84.9% | 0.00% | – |
| Q4 2022 | $202,757 | +28.3% | 28,318 | -9.9% | 0.00% | – |
| Q3 2022 | $158,000 | +209.8% | 31,444 | +51.2% | 0.00% | – |
| Q2 2022 | $51,000 | -83.4% | 20,798 | -53.7% | 0.00% | – |
| Q1 2022 | $307,000 | -33.4% | 44,946 | -21.2% | 0.00% | – |
| Q4 2021 | $461,000 | +16.7% | 57,003 | +41.3% | 0.00% | – |
| Q3 2021 | $395,000 | +70.3% | 40,349 | +16.9% | 0.00% | – |
| Q2 2021 | $232,000 | +29.6% | 34,515 | +73.8% | 0.00% | – |
| Q1 2021 | $179,000 | -64.5% | 19,854 | -73.7% | 0.00% | – |
| Q4 2020 | $504,000 | +300.0% | 75,375 | +202.0% | 0.00% | – |
| Q3 2020 | $126,000 | -96.4% | 24,959 | -94.3% | 0.00% | -100.0% |
| Q1 2020 | $3,505,000 | +8448.8% | 441,440 | +2659.0% | 0.00% | – |
| Q4 2018 | $41,000 | -55.4% | 16,000 | -23.4% | 0.00% | – |
| Q3 2018 | $92,000 | -60.0% | 20,877 | -44.2% | 0.00% | – |
| Q2 2018 | $230,000 | +19.2% | 37,447 | +41.3% | 0.00% | – |
| Q1 2018 | $193,000 | -10.6% | 26,510 | +0.8% | 0.00% | – |
| Q4 2017 | $216,000 | -41.5% | 26,298 | -25.2% | 0.00% | – |
| Q3 2017 | $369,000 | +0.5% | 35,159 | +5.7% | 0.00% | – |
| Q2 2017 | $367,000 | -50.7% | 33,271 | -56.8% | 0.00% | – |
| Q1 2017 | $745,000 | – | 76,938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |